Irritable bowel syndrome helped by montelukast (6)

Chest

Volumn 122, Issue 4, 2002, Pages 1497-

  Fee, William H ^a  

^a Chest Medicine Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE;

ASTHMA; BRONCHOSPASM; CELIAC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIARRHEA; DIET; DRUG ACTIVITY; DRUG EFFECT; GLUTEN FREE DIET; HUMAN; IRRITABLE COLON; LETTER; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0036430794     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.4.1497     Document Type: Article

References (4)

1. Holma R, Salmenpera P, Riutta A, et al. Acute effects of the cys-leuktriene-1 receptor antagonist, montelukast, on experimental colitis in rats. Eur J Pharmacol 2001; 429:309-318
2. Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci 2001; 46:1787-1790
3. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346: 180-187
4. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001; 358:504-508